← Back to Search

Walnut Intake for Cardiovascular Risk

N/A
Waitlist Available
Led By Roberta R Holt, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 weeks
Awards & highlights

Study Summary

This trial will enroll postmenopausal women who are at risk for cardiovascular disease due to their menopausal status and increased central adiposity. The study will assess the 12 week influence of 40 g of daily walnut intake on the health of overweight and obese postmenopausal women.

Eligible Conditions
  • Cardiovascular Risk
  • Endothelial Dysfunction
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Framingham Reactive Hyperemia Index (fRHI)
Reactive Hyperemia Index (RHI)
Secondary outcome measures
ADP-Induced Platelet Aggregation
Collagen-Induced Platelet Aggregation
Ellagitannin Metabolites
+7 more
Other outcome measures
Blood Pressure
Complete Blood Cell Count
Complete Metabolic Panel
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Walnut IntakeExperimental Treatment1 Intervention
Experimental Arm of 12 weeks of Walnut Intake, with study visits at baseline (prior to walnut intake) and after 6 and 12 weeks of 40g of Walnut Intake.
Group II: Habitual IntakeActive Control1 Intervention
This will be the comparative arm, of 6 weeks before and after the study participant is on their habitual diet

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,695 Total Patients Enrolled
4 Trials studying Cardiovascular Risk
166 Patients Enrolled for Cardiovascular Risk
Roberta R Holt, PhDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
9 Total Patients Enrolled
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top